Pharmaceutical combination of Aliskiren and Valsartan

Details for Australian Patent Application No. 2008309059 (hide)

Owner Novartis AG

Inventors Gerber, Frederic; Becker, Dieter; Curdy, Catherine; Li, Shoufeng; Schlutermann, Burkhard

Agent Davies Collison Cave

Pub. Number AU-A-2008309059

PCT Pub. Number WO2009/045796

Priority 60/975,905 28.09.07 US

Filing date 24 September 2008

Wipo publication date 9 April 2009

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/045796 Priority application(s): WO2009/045796

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008309063-Treatment of cardiovascular disorders using the cell differentiation signaling protein Nell1

2008309058-Galenical formulations of Aliskiren and Valsartan